Reuters logo
CORRECTED-BRIEF-Cascadian says stockholder Growth Equity Opportunities Fund IV has option to resell 1.82 mln of co's shares (May 8)
May 10, 2017 / 2:59 PM / 7 months ago

CORRECTED-BRIEF-Cascadian says stockholder Growth Equity Opportunities Fund IV has option to resell 1.82 mln of co's shares (May 8)

(Corrects May 8 brief headline to say company’s stockholder Growth Equity Opportunities Fund IV, not Cascadian, may resell up to 1.82 million shares. Adds bullets with additional details of financing)

May 10 (Reuters) - Cascadian Therapeutics Inc

* Files S-3 related to possible resale of up to 1.82 million shares of common stock by Growth Equity Opportunities Fund IV and its affiliates - SEC filing

* Growth Equity Opportunities Fund IV has option to resell common shares of the company, as part of Series E preferred stock financing announced in January by Cascadian

* S-3 filing is not related to a new secondary issue by Cascadian

* Cascadian will not receive any cash proceeds from the possible sale of any of shares of common stock by Growth Equity Opportunities Fund Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below